Lisa Paley

Lisa Paley was appointed Chief Executive Officer of Revision Skincare in September 2025. Paley joins from Haleon, where she served as President of North America and was a founding member of the Executive Leadership Team. During her tenure, she led the company's North American business through its corporate spin-off from GSK and its public listings on both the New York Stock Exchange and the Financial Times Stock Exchange.

At Haleon and GSK Consumer Healthcare, Paley initiated advancements in AI-driven marketing, e-commerce, strategic revenue management, and organizational culture and engagement. Prior to GSK, she held senior roles at Pfizer Consumer Healthcare, ultimately serving as President, North America, with P&L responsibility over the US, Canada and the Caribbean. Paley also previously served as VP of US Sales at Johnson & Johnson.

A former Certified Public Accountant, she began her career at Deloitte. Paley holds a BS in Accounting from Miami University and an Executive MBA from The Ohio State University. Paley previously served as Chairman of the Board of the Consumer Healthcare Products Association (CHPA) and led the National Association of Chain Drug Stores (NACDS) Retail Advisory Board. She has also served as a board member of NextUp, Excel Share Group and WE, an organization dedicated to expanding women's voices in the consumer health and wellness space.

Career History

• Chief Executive Officer, Revision Skincare (2025–present)
• President, North America, Haleon (2019–2025)
• President, North America, GSK Consumer Healthcare joint venture with Pfizer
• President, North America, Pfizer Consumer Healthcare
• Vice President, US Sales, Johnson & Johnson
• Certified Public Accountant, Deloitte

What Lisa Paley could bring to CEO of Revision Skincare: Paley brings a strong track record of driving innovation, including work in AI-driven marketing, e-commerce, and organizational transformation. Her multi-decade experience scaling science-backed consumer health brands across North America and navigating major corporate transitions positions her to expand Revision Skincare's physician-dispensed skincare footprint and accelerate growth in the converging beauty and wellness categories.

This is an automatically generated Light profile created by Executive Moves editorial systems from verified public announcements. Information is kept deliberately concise until the page is claimed and enriched.